Literature DB >> 18333280

Prognostic value of p27 kip1 expression in adenocarcinoma of the pancreatic head region.

Jerzy Mielko1, Wojciech P Polkowski, Danuta G Skomra, Andrzej J Stanisławek, Andrzej M Kurylcio, Elzbieta M Korobowicz.   

Abstract

BACKGROUND: p27(kip1) is a tumour suppressor gene, functioning as a cyclin-dependent kinase inhibitor, and an independent prognostic factor in breast, colon, and prostate adenocarcinomas. Conflicting data are reported for adenocarcinoma of the pancreas. The aim of this study was to establish the prognostic value of p27(kip1) expression in adenocarcinoma of the pancreatic head region. PATIENTS AND METHODS: The study included 45 patients (male/female ratio 2:1; mean age 59, range 38-82 years) with adenocarcinomas of the pancreatic head region: 24 - pancreatic head, 18 - periampullary and 3 - uncinate process. The patients underwent the Kausch-Whipple pancreatoduodenectomy (n=39), pylorus-preserving pancreatoduodenectomy (n=5), or nearly total pancreatectomy (n=1). Eight patients received adjuvant chemotherapy postoperatively. Follow-up time ranged from 3 to 60 months. Tumours were staged according to the pTNM classification (UICC 1997). Immunohistochemistry was done on paraffin-embedded blocks from tumour sections. Quantitative determination of p27(kip1) expression was based on the proportion of p27(kip1) -positive cells (< 5% = negative). Survival analysis was carried out using the Kaplan-Meier method and Cox regression model.
RESULTS: Positive p27(kip1) expression was detected in 22 tumours (49%), whereas 23 tumours (51%) were p27(kip1)-negative. There were no significant correlations between p27(kip1) index and stage or lymph node involvement. Median survival time in patients with p27(kip1)-positive tumours was 19 months, whereas in patients with p27(kip1)-negative tumours it was 18 months (p=0.53). A significant relationship was found between p27(kip1)-negative tumours and radical resection (p=0.04). Multivariate survival analysis revealed that the localization of the tumour (pancreatic head/uncinate process vs periampullary) was the only significant and independent prognosticator (p = 0.01, Cox regression model). Resection margins involvement and grade remained nearly significant prognostic factors (p=0.07 and p=0.09, respectively).
CONCLUSION: We conclude that p27(kip1) has limited overall prognostic utility in resected carcinoma of the pancreatic head region, but its potential role as a marker of residual disease needs to be further assessed.

Entities:  

Year:  2006        PMID: 18333280      PMCID: PMC2131676          DOI: 10.1080/13651820500537739

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  42 in total

1.  Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27.

Authors:  Y Katayose; M Kim; A N Rakkar; Z Li; K H Cowan; P Seth
Journal:  Cancer Res       Date:  1997-12-15       Impact factor: 12.701

2.  CA 19-9 serum course and prognosis of pancreatic cancer.

Authors:  F Safi; W Schlosser; S Falkenreck; H G Beger
Journal:  Int J Pancreatol       Date:  1996-12

3.  Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents.

Authors:  B St Croix; V A Flørenes; J W Rak; M Flanagan; N Bhattacharya; J M Slingerland; R S Kerbel
Journal:  Nat Med       Date:  1996-11       Impact factor: 53.440

4.  Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.

Authors:  M Määttä; Y Soini; A Liakka; H Autio-Harmainen
Journal:  Clin Cancer Res       Date:  2000-07       Impact factor: 12.531

Review 5.  Regulation of the cdk inhibitor p27 and its deregulation in cancer.

Authors:  J Slingerland; M Pagano
Journal:  J Cell Physiol       Date:  2000-04       Impact factor: 6.384

6.  Classification of pancreatic cancer: comparison of Japanese and UICC classifications.

Authors:  Shuji Isaji; Yoshifumi Kawarada; Shinji Uemoto
Journal:  Pancreas       Date:  2004-04       Impact factor: 3.327

7.  p27 Kip1 expression is reduced in pancreatic carcinoma but has limited prognostic value.

Authors:  Roger M Feakins; Adeel H Ghaffar
Journal:  Hum Pathol       Date:  2003-04       Impact factor: 3.466

8.  Loss of p27 nuclear expression in a prognostically favorable subset of well-differentiated pancreatic endocrine neoplasms.

Authors:  Ayman Rahman; Anirban Maitra; Raheela Ashfaq; Charles J Yeo; John L Cameron; Donna E Hansel
Journal:  Am J Clin Pathol       Date:  2003-11       Impact factor: 2.493

9.  Expression of p27(kip1), Rb protein and proliferating cell nuclear antigen and its relationship with clinicopathology in human pancreatic cancer.

Authors:  Hui Yue; Fu-Lin Song; Ning Zhang; Xin-Li Feng; Tian-Yi An; Jie-Ping Yu
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2003-02

10.  Periampullary adenocarcinoma: analysis of 5-year survivors.

Authors:  C J Yeo; T A Sohn; J L Cameron; R H Hruban; K D Lillemoe; H A Pitt
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.